Abeona Therapeutics Inc. (NASDAQ:ABEO) went up by 25.28% from its latest closing price compared to the recent 1-year high of $26.50. The company’s stock price has collected 45.07% of gains in the last five trading sessions. Is It Worth Investing in Abeona Therapeutics Inc. (NASDAQ :ABEO) Right Now
Abeona Therapeutics (NASDAQ:ABEO – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday, Zacks.com reports. The firm currently has a $0.25 price target on the biopharmaceutical company’s stock. Zacks Investment Research‘s target price indicates a potential upside […]
Abeona Therapeutics (NASDAQ:ABEO – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Friday, Zacks.com reports. According to Zacks, “Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known […]
Abeona Therapeutics Inc (NASDAQ:ABEO – Get Rating) – Equities researchers at Cantor Fitzgerald increased their FY2022 earnings per share (EPS) estimates for Abeona Therapeutics in a research note issued to investors on Wednesday, May 18th. Cantor Fitzgerald analyst K. Kluska now forecasts that the biopharmaceutical company will earn ($0.43) per share for the year, up […]
Abeona Therapeutics (NASDAQ:ABEO – Get Rating) posted its quarterly earnings data on Friday. The biopharmaceutical company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.04), Fidelity Earnings reports. NASDAQ ABEO remained flat at $$0.16 on Friday. 1,401,582 shares of the company were exchanged, compared to its average volume […]